Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Taste Properties of HIV Inhibitor [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the taste properties of an HIV inhibitor sponsored by ViiV Healthcare has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HIV Inhibitor (taste properties study)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED